data submitted voluntarily to the Collaborative Transplant Study. 3 Country outcomes within Europe were not analyzed.
The overall effectiveness of well-established kidney transplant systems, using graft failure as the outcome of interest, has not been studied at a country level. Rather than undertake an individual patient data meta-analysis, the opportunity to use detailed patientlevel longitudinal data from transplants performed over the last quarter century in 4 countries on 3 continents and reported to registries with robust data tracking, motivated us to perform a study with the overarching goal to determine the existence and magnitude of country-level differences in kidney graft outcome.
| MATERIAL S AND ME THODS
Patient-level data were combined from 3 transplant registries cover- Recipient race and primary renal diagnosis were missing for 33%
and 38% of United Kingdom recipients, respectively. Ischemia time for deceased donor transplants was missing for 2.4%, 7.9%, 46.5%, and 26.8% of transplants in Australia, New Zealand, the United Kingdom, and the United States, respectively, and for living donor transplants for 1.5%, 0.5%, 20.7%, and 44.0%, respectively. In the United Kingdom, recipient race and ischemia time were not collected until 1998 and 2000, respectively. Donor cause of death was missing for 2.7% and 6.2% of Australia and New Zealand cases, respectively.
The number of HLA mismatches was missing for 4.7% and 1.8% of transplants in Australia and New Zealand, respectively. For the remaining country and variable combinations, values were missing for no more than 1% of subjects (full list of covariates given below).
As recommended by Little et al, 6, 7 missing data were handled by multiple imputation using the sequential regression imputation method, 8 implemented with the Impute module of the IVEware software package. 9 We performed 40 imputations for missing data. Model results from individual imputations were combined using SAS Proc
MIAnalyze to calculate overall the effect estimates and significance levels presented in the paper. 7 Results of models fitted from complete case data (Table S1) were very similar to those that used imputed data.
Descriptive statistics are given as median (quartile 1 to quartile 3)
for continuous variables and as percentages for categorical factors.
Cox regression models were used to compare risk-adjusted graft failure among the study countries. Separate models were fit- To test the robustness of our long-term model within covariate sub-cohorts, we tested whether country-specific hazard ratios for the long-term risk of graft failure varied across study subcohorts defined by the levels or categories of each tested covariate.
In each model, we examined the country-specific risk of graft failure restricted to a subcohort defined by a specific level or category of one covariate. This was repeated for each level of all covariates, with each model adjusted for all other covariates. Country-specific hazard ratio P-values were adjusted using the stepdown Bonferroni adjustment for multiple comparisons. 10 We examined trends in country-specific hazard ratios over calendar time with graft failure models that included country, year of transplant (continuous), and country-by-year interaction terms.
We explored the sensitivity of our results to the effect of potential unmeasured confounders using the method of Lin et al, 11 depicted graphically according to Weintraub et al. 12 This method allowed us to assess whether significant differences in country-specific risks of long-term graft failure could be explained by an unmeasured patientlevel confounder with disparate prevalence across countries.
Statistical analyses were carried out using SAS version 9.4 (SAS Institute; Cary, NC). Results with a 2-sided P-value ≤ .05 were considered statistically significant.
| RE SULTS

| Descriptive statistics
There were 379 257 kidney transplants performed in the 4 countries from 1988 to 2014. Characteristics of the study cohort are shown in 
| Time trend in country-specific graft failure risk
The risk of short-term graft failure decreased significantly over the 27-year cohort period (each within-country slope P < .001) ( Figure 2A ). In 1988, 1-year risk was significantly higher in New
Zealand and the United Kingdom than in the United States (P < .001).
Thereafter, a larger decrease in 1-year graft failure risk occurred 
| Possibility of an unmeasured confounder
We examined whether the significantly higher risk of long-term graft failure after kidney transplant in the United States could be explained by residual confounding by unmeasured factors. To negate the observed country-specific differences, there would need to be a strong enough association between the unmeasured factor, and sufficiently disparate prevalence of that confounder, to cause the upper 95% confidence limit of the country-specific hazard ratio to cross 1.0. Various combinations of effect sizes (hazard ratios) of a putative confounder and disparate prevalences in the recipients of comparator countries were tested. hazard ratios. These represent combinations where the upper 95% confidence limit of the hazard ratio for recipients in Australia versus the United States (0.77) would be elevated to 1.00 by inclusion of the unmeasured confounder. Given the existence of an unmeasured factor with a hazard ratio of 2.0, Figure 3 shows that the observed difference between the United States and Australia could be explained only by a factor that was at least 31 percentage points more prevalent in the United States than Australia, for example, 36% vs 5% or lower, respectively. For the United Kingdom, the difference in prevalence compared to the United States would need to be at least 35 percentage points to explain the difference in long-term graft survival, whereas the difference for New Zealand would need to be at least 26 percentage points. For unmeasured confounders with hazard ratios closer to 1.0, the corresponding required disparity in prevalence was even greater.
| D ISCUSS I ON
Kidney transplantation is an effective treatment for end-stage renal disease, but a search for opportunities to improve long-term allograft function deserves attention. With the goal to learn from differences in outcomes, this collaborative study used detailed observational data reported to well-established transplant registries on 3 continents to assess differences in kidney graft outcomes across 4 countries using a uniform analytical methodology. We found that recipients in the United States had a lower risk of graft failure in the first posttransplantation year compared to patients transplanted in the United Kingdom and New Zealand (but not significantly different than Australians). Although 1 year is the traditional short-term milepost for assessing outcome in kidney transplantation, long-term outcome is a more relevant patient-centered metric. We found that the risk of long-term graft failure among those whose grafts were functioning at 1 year was approximately 25% lower in Australia, New Zealand, and the United Kingdom than in the United States. In patient-centered terms, this represents 3 years of forfeited kidney graft function time for the average recipient in the United States.
To evaluate the possibility that the striking differences in overall graft failure risk-despite extensive statistical adjustment for confounding covariates-were driven by heterogeneity of effects, we leveraged the large size of our cohort to focus on subcohorts.
Compared to the United States, lower long-term risk was consistently 
TA B L E 1 (Continued)
F I G U R E 1 Adjusted graft survival by country for (A) 1-year follow-up (n = 379 257, graft failures = 33 981) and (B) long-term follow-up conditional on being alive with a functioning graft at 1 year (n = 318 048, graft failures = 119 322). Survival curves for each country were generated using average covariate values of the entire study cohort. Note that in panel (A) the y-axis has a break that zooms in on the upper part of the range to make the differences in short-term graft survival more easily visible .033
TA B L E 2 Adjusted risk of long-term graft failure versus the United States by covariate subcohorts
1.000
1.000
Bold face indicates statistically significant results. Each row below represents a separate Cox regression. *P-values were adjusted for multiple comparisons using stepdown Bonferroni method. We had access to rich clinical datasets from all 4 countries; the 3 registries selected for this study had comparable data collection methods, analytical conventions, and longitudinal follow-up. conditions that contribute to graft failure than recipients elsewhere. 16 If such data were available, and if their inclusion as adjustment covariates negated the observed excess long-term graft failure risk in the United States patients, it would explain why results were worse in the United States. We did not have uniform data on panel reactive antibody levels, but the majority of first-time kidney transplant recipients are unsensitized. In the current study, we adjusted for the presence or absence of diabetes mellitus, but we did not have access to patient-level data on cardiovascular disease, peripheral vascular disease, or other conditions. Conceptually, however, one or more variables important enough to negate our findings would have required, in aggregate, a very large effect size, combined with highly disparate prevalence in United States and non-United States recipients. This seems unlikely from a clinical standpoint, given the relative stringency of kidney transplant recipient eligibility assessment. As a further step, our study included a specific quantification of the possibility of unmeasured confounding using a method reported in other observational studies 12 ; the results cast doubt on unmeasured confounding as the explanation for country-specific differences in outcome.
TA B L E 2 (Continued
Limitations of the present study include the possibility of underascertainment of graft failure or death. However, each of the registries used supplemental data sources to capture dialysis or death.
Race was based on registry files and may not be patient reported, a common problem in most clinical studies. Data on race were not available for early years in the United Kingdom; however, sensitivity analyses using complete case data were consistent with the main analyses performed using multiple imputation.
International studies of chronic diseases can reveal differences in outcomes that result from country-specific medical practice patterns or healthcare delivery systems that are exogenous to patient characteristics. In the Dialysis Outcomes and Practice Patterns Study, an international prospective observational study of hemodialysis patients, detailed adjustment for multiple comorbid conditions failed to explain excess mortality among United States dialysis patients, whereas more than half of the excess was accounted for by country-specific differences in vascular access practices. 17 In kidney transplantation, time-limited insurance coverage for immunosuppressive medication may mediate impaired longterm outcome in low-income recipients in the United States 18 and income-based outcome disparities were ameliorated after a 3-year coverage limitation ended. 19 In each of the countries other than the United States studied here, health insurance coverage and medication availability are universal. Our sub-analysis showed that recipients in the United States with private health care insurance and government-funded health care insurance (Medicare/Medicaid) each had significantly higher risks of long-term graft failure than recipients in Australia, New Zealand, and the United Kingdom.
Aside from healthcare insurance, there are other differences in health care systems and potentially identifiable differences in F I G U R E 3 Effect of potential unmeasured confounder. The graph shows how large an effect and/or disparity in prevalence of a single confounder would need to be to explain the superior long-term graft outcome in Australia compared to the United States. For a given prevalence in Australia (each line represents a given prevalence) and in the United States (depicted on the x-axis), the values on the y-axis represent the hazard ratios for graft failure that would be required to account for the difference in the observed risk of graft failure. The dot in the figure represents the example of an unmeasured confounder with a hazard ratio of 2.0. A prevalence of 36% in the United States and 5% or less in Australia would be necessary to negate the observed difference in long-term outcome. Adapted from Weintraub et al posttransplantation care practice patterns that would be candidates to study as factors leading to disparate kidney transplant outcomes around the world. Focused studies of transplant center practices (eg, the extent to which uniform patient care guidelines are used; the timing and extent of return of care responsibility from the transplant center to local physicians; differences in immunosuppression practices) are needed to better understand the differences in outcome we observed and to suggest interventions in posttransplantation care to test as best practices.
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